FibroGen Inc (FGEN)

8.60
+0.03(+0.35%)
After Hours
8.50
-0.10(-1.16%)
- Real-time Data
  • Volume:
    894,398
  • Day's Range:
    8.20 - 8.80
  • 52 wk Range:
    7.81 - 30.12

FGEN Overview

Prev. Close
8.57
Day's Range
8.2-8.8
Revenue
257.7M
Open
8.8
52 wk Range
7.81-30.12
EPS
-3.04
Volume
894,398
Market Cap
802.36M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
852,958
P/E Ratio
-
Beta
0.91
1-Year Change
-59.64%
Shares Outstanding
93,297,542
Next Earnings Date
Aug 08, 2022
What is your sentiment on FibroGen Inc?
or
Market is currently closed. Voting is open during market hours.

FibroGen Inc News

FibroGen Inc Analysis

FibroGen Inc Company Profile

FibroGen Inc Company Profile

Employees
566

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell
  • Lets start!
    0
    • 4 BIOTECH STOCKS FACING FDA REJECTION!Is it a full stop or a pause to their journey?https://www.reddit.com/r/MicrocapStocksRun/comments/palt5t/4_biotech_stocks_facing_fda_rejection/?utm_source=share&utm_medium=web2x&context=3
      1
      • Target for today?
        1
        • Balance Sheet looks good. They hit rock bottom under 20. just need some good news and then .... 🚀🌙
          1
          • Target guys ?
            1
            • $19
              0
            • 28
              0
          • Not bad
            1
            • 21 today
              3
              • Run baby
                2
                • Go to the moon
                  1
                  • Soounds like good news!
                    0